NCT03550521 is a NA clinical trial of Mindfulness in Nonsuicidal Self-injury, sponsored by University of Utah.

Who is sponsoring NCT03550521?

NCT03550521 is sponsored by University of Utah.

What drugs are being tested in NCT03550521?

Interventions in NCT03550521: Mindfulness.

What condition does NCT03550521 study?

NCT03550521 studies Nonsuicidal Self-injury.

Is NCT03550521 still recruiting?

NCT03550521 is currently withdrawn. Last updated 28 April 2021.

Last reviewed 2021-04-28 · How we verify

NCT03550521

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interrupting Self-Harm Study

Withdrawn NA Last updated 28 April 2021

What this trial tests

NA trial testing Mindfulness in Nonsuicidal Self-injury. Withdrawn.

Timeline

1 June 2018

Primary endpoint
1 June 2019

1 June 2019

Quick facts

Lead sponsor	University of Utah
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Start date	1 June 2018
Primary completion	1 June 2019
Estimated completion	1 June 2019
Sites	1 location across United States

Drugs / interventions tested

Mindfulness

Conditions studied

Nonsuicidal Self-injury — all drugs for Nonsuicidal Self-injury →

Sponsor

University of Utah

Who can join

Adults 12 to 18, any sex, with Nonsuicidal Self-injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

My study will employ a convergent mixed methods two-arm parallel randomized controlled design. The qualitative strand will primarily rely on semi-structured interview procedures to answer the following questions: (1) How do adolescents perceive and experience the phenomenon of nonsuicidal self-injury (NSSI)? (2) What do adolescents believe needs to be done to address NSSI? The quantitative strand will primarily rely on clinical interview data, self-report measures, and an experimental task protocol to answer the following question: What is the impact of a brief mindfulness induction (versus a control condition) on self-injury attentional bias among self-injuring adolescents?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interventions for self-harm in children and adolescents.
Witt KG, Hetrick SE, Rajaram G, Hazell P, et al · · 2021 · cited 90× · PMID 33677832 · DOI 10.1002/14651858.cd013667.pub2

Verify or expand the search:

Other trials of Mindfulness

Trials testing the same drug.

NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07335159 — Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention · NA · recruiting
NCT07216417 — TeleYoga for Chronic Low Back Pain: A Quantitative and Qualitative Study · NA · active not recruiting
NCT07346339 — Sensory Mindfulness for NICU Mothers: Effects on Breast Milk, Well-Being, and Stress · NA · completed

Other University of Utah trials

Trials by the same sponsor.

NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
NCT07225426 — Personalizing Financial Incentives · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
NCT04208984 — Diversion Device With Breath Control · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03550521 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 28 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03550521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing